Unlike kyphoplasty which involves the insertion of a ballon into the patients fractured bone, our rotoplasty device utilizes one or multiple blades (depending on the patient’s condition) which are then inserted into the vertebra in a collapsed position. What’s most revolutionary is that the blades are capable of being deployed into an expanded position inside the marrow cavity, and rotated to cut a “path of least resistance” in the bone marrow. This allows more control of the flow of the cement in marrow space, proving to make it more effective than traditional methods.
Coincidentally, it is also more cost effective.
Minimally invasive vertebral compression fracture repair is one of the fastest growing segments in the overall spinal surgeries market, estimated at $1.5 billion in 2012 and expected to grow at a CAGR of 8.7% from 2013 to $2.82 billion 2019 with kyphoplasty representing $1.47 billion and vertebroplasty at $1.35 billion. Our device is aimed at keeping costs lower for both physicians and patients, allowing for more individuals to be treated and more volume of patients for physicians, as well as improved ease of use.
In addition, the device and fixation system is designed to preserve the stem cells present in bone marrow that may then mature into active bone cells to eventually replace the bone binding material with natural bone.